Decreased plasma adiponectin concentrations in nondiabetic women with elevated homeostatis model assessment ratios

European Journal of Endocrinology

Volumn 148, Issue 3, 2003, Pages 343-350

  Matsubara, Miyao ^b   Katayose, Shinji ^a   Maruoka, Shoji ^a  

^a Otsuka Assay Institute   (Japan)

^b Otaru City General Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; INSULIN; LEPTIN; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BODY MASS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HOMEOSTASIS; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; JAPAN; MAJOR CLINICAL STUDY; MULTIPLE REGRESSION; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; TRIACYLGLYCEROL BLOOD LEVEL; VALIDATION PROCESS;

ADIPONECTIN; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AGING; BLOOD PRESSURE; BODY MASS INDEX; CHOLESTEROL; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HOMEOSTASIS; HUMANS; INSULIN; INSULIN RESISTANCE; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; JAPAN; LEPTIN; MIDDLE AGED; MODELS, BIOLOGICAL; PROTEINS; REGRESSION ANALYSIS; TRIGLYCERIDES;

EID: 0037357147     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1480343     Document Type: Article

References (34)

1. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988 37 1597-1607.
2. Stout RW. Insulin and atheroma: a 20-yr perspective. Diabetes Care 1990 13 631-654.
3. Pyorala M, Miettinen H, Laakso M & Pyorala K. Hyperinsulinemia predicts coronary heart disease risk in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study. Circulation 1998 98 398-404.
4. Bonora E, Tessari R, Micciolo R, Zenere M, Targher G, Padovani R et al. Intimal-medial thickness of the carotid artery in nondiabetic and NIDDM patients: relationship with insulin resistance. Diabetes Care 1997 20 627-631.
5. Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y & Matsubara K. cDNA cloning and expression of a novel adipose specific collagen-like factor, apMI (adipose most abundant gene transcript 1). Biochemical and Biophysical Research Communications 1996 221 286-289.
6. Okamoto Y, Arita Y, Nishida M, Muraguchi M, Ouchi N, Takahashi M et al. An adipocyte-derived plasma protein, adiponectin, adheres to injured vascular walls. Hormone and Metabolic Research 2000 32 47-50.
7. Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 1999 100 2473-2476.
8. Yokota T, Oritani K, Takahashi I, Ishikawa J, Matsuyama A, Ouchi N et al. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood 2000 96 1723-1732.
9. Ouchi N, Kihara S, Arita Y, Nishida M, Matsuyama A, Okamoto Y et al. Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation 2001 103 1057-1063.
10. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochemical and Biophysical Research Communications 1999 257 79-83.
11. Matsubara M, Maruoka S & Katayose S. Inverse relationship between plasma adiponectin and leptin concentrations in normal-weight and obese women. European Journal of Endocrinology 2002 147 173-180.
12. Matsubara M, Maruoka S & Katayose S. Decreased plasma adiponectin concentrations in women with dyslipidemia. Journal of Clinical Endocrinology and Metabolism 2002 87 2764-2769.
13. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arteriosclerosis and Thrombosis and Vascular Biology 2000 20 1595-1599.
14. Hotta K, Funahashi T, Bodkin NL, Ortmeyer HK, Arita Y, Hansen BC et al. Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes 2001 50 1126-1133.
15. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Platley RE et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. Journal of Clinical Endocrinology and Metabolism 2001 86 1930-1935.
16. Matsubara M, Yoshizawa T, Morioka T & Katayose S. Serum leptin and lipids in patients with thyroid dysfunction. Journal of Atherosclerosis and Thrombosis 2000 7 50-54.
17. Mantzoros CS. The role of leptin in human obesity and disease: a review of current evidence. Annals of Internal Medicine 1999 130 671-680.
18. Matsubara M, Chiba H, Maruoka S & Katayose S. Elevated serum leptin concentrations in women with components of multiple risk factor clustering syndrome. Journal of Atherosclerosis and Thrombosis 2000 7 231-237.
19. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF & Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985 28 412-419.
20. Bonora E, Saggiani F, Targher G, Zenere MB, Alberiche M, Monauni T et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity Diabetes Care 2000 23 57-63.
21. Imagawa A, Funahashi T, Nakamura T, Moriwaki K, Tanaka S, Nishizawa H et al. Elevated serum concentration of adipose-derived factor, adiponectin, in patients with type 1 diabetes. Diabetes Care 2002 25 1665-1666.
22. Kissebah AH, Sonnenberg GE, Myklebust J, Goldstein M, Broman K, James RG et al. Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome. PNAS 2000 97 14478-14483.
23. Vionnet N, Hani El-H, Dupont S, Gallina S, Francke S, Dotte S et al. Genome wide search for type 2 diabetes-susceptibility gene in French white: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24. American Journal of Human Genetics 2000 67 1470-1480.
24. Takahashi M, Arita Y, Yamagata K, Matsukawa Y, Okutomi K, Horie M et al. Genomic structure and mutations in adipose-specific gene, adiponectin. International Journal of Obesity 2000 24 861-868.
25. Hara K, Boutin P, Mori Y, Tobe K, Dina C, Tasuda K et al. Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes 2002 51 536-540.
26. Kondo H, Shimomura I, Matsukawa Y, Kumada M, Takahashi M, Matsuda M et al. Association of adiponectin mutation with type 2 diabetes. Diabetes 2002 51 2325-2328.
27. Menzaghi C, Ercolino T, Paola RD, Berg AH, Warram JH, Scherer PE et al. A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome. Diabetes 2002 51 2306-2312.
28. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nature Medicine 2001 7 941-946.
29. Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF & Spiegelman BM. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science 1996 271 665-668.
30. Cheung AT, Ree D, Koll JK, Fuselier J, Coy DH & Bryer-Ash M. An in vivo model for elucidation of the mechanism of tumor necrosis factor-alpha (TNF-alpha)-induced insulin resistance: evidence for differential regulation of insulin signalling by TNF-alpha. Endocrinology 1998 139 4928-4935.
31. Hotamisligil GS, Arner P, Caro JF, Atkinson RL & Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance. Journal of Clinical Investigation 1995 95 2409-2415.
32. Saghizadeh M, Ong JM, Garvey WT, Henry RR & Kern PA. The expression of TNFα by human muscle: relationship to insulin resistance. Journal of Clinical Investigation 1996 97 1111-1116.
33. Fasshauer M, Klein J, Neumann S, Eszlinger M & Paschke R. Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes. Biochemical and Biophysical Research Communications 2002 290 1084-1089.
34. Berg AH, Combs TP, Du X, Brownlee M & Scherer PE. The adipocyte-secreted protein Acrp 30 enhances hepatic insulin action. Nature Medicine 2001 7 947-953.